{
    "2018-03-19": [
        [
            {
                "time": "2018-03-19",
                "original_text": "平安研报20180319",
                "features": {
                    "keywords": [
                        "医药股",
                        "基金经理",
                        "逻辑",
                        "医院终端用药结构变化",
                        "投资机会"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "[强于大市评级]医药生物行业专题研究：机构改革组建医药三大部门 监管开启新篇章",
                "features": {
                    "keywords": [
                        "医药生物",
                        "机构改革",
                        "监管",
                        "新篇章"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "[推荐评级]医药行业周报：医改新猜想 行业新机会",
                "features": {
                    "keywords": [
                        "医药",
                        "医改",
                        "新机会"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "[强于大市评级]医药生物行业研究周报：医药部委体系调整 改革箭在弦上",
                "features": {
                    "keywords": [
                        "医药生物",
                        "部委体系调整",
                        "改革"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "[看好评级]PHARMACEUTICAL: PROMISING INVESTMENT THEMES IN PHARMACEUTICAL INDUSTRY：DRUG PRODUCERS CONSUMP.",
                "features": {
                    "keywords": [
                        "医药",
                        "投资主题",
                        "药品生产商"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}